Therefore, we decided to further investigate the differences between CAV1-High and CAV1-Low expressing mature T-cell lymphoma samples in an effort to characterize the impact of CAV1 on the tumor microenvironment (TME). The gene discussed is CAV1; the disease is T-cell non-Hodgkin lymphoma.